The Bactekill hand sanitizer has been announced by Eagle Labs as a new product that will be produced at a high volume by the brand to help offer additional support for consumers during the COVID-19 pandemic. The product is a high-quality over-the-counter hand sanitizer that has been developed by scientists who boast more than 30 years of experience in the field. The brand has registered with the Food and Drug Administration for the product, and features 70% alcohol to ensure it is suitable for killing harmful pathogens on contact.
The Bactekill hand sanitizer is reported by the brand to deliver exceptional cleaning capabilities, while also leaving a good skin feel to ensure it's suitable for continuous use.
What's Driving This Trend
- High-volume Sanitizer Production
- Brands should invest in high-volume production of hand sanitizers to meet the demand for cleanliness and protection amidst the COVID-19 pandemic.
- Scientific Expertise in Sanitizer Development
- There is an opportunity for scientists with expertise in hand sanitizer development to innovate and create high-quality solutions with added benefits like a good skin feel.
- Effective Germ-killing Formulas
- Innovations in hand sanitizers should prioritize effective germ-killing formulas, such as those with 70% alcohol content, to provide maximum protection against harmful pathogens.
Who This Affects Most
- Personal Care
- Opportunities exist for personal care brands to expand their product lines with high-quality hand sanitizers that offer germ-killing benefits and a good skin feel.
- Healthcare
- In the healthcare industry, there is a need for high-quality hand sanitizers to ensure the safety and protection of patients, healthcare workers, and visitors.
- Manufacturing
- Manufacturing companies have an opportunity to pivot their production lines towards hand sanitizers to meet the increased demand for protective products during the COVID-19 pandemic.
